Product of serum calcium and phosphorus (Ca × PO4) as predictor of cardiovascular disease risk in predialysis patients.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Clinical Biochemistry

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.clinbiochem.2013.09.012PMID 24064489
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cardiovascular Risk and Mineral Bone Disorder in Patients with Chronic Kidney Disease

  2013cited by this paper
• Uraemic vasculopathy in children with chronic kidney disease: prevention or damage limitation?

  2011cited by this paper
• Conjoint Effects of Serum Calcium and Phosphate on Risk of Total, Cardiovascular, and Noncardiovascular Mortality in the Community

  2010cited by this paper
• Atherosclerosis in CKD: differences from the general population

  2010cited by this paper
• Clinical epidemiology of cardiovascular disease in chronic kidney disease.

  2010cited by this paper
• Outcomes associated with serum calcium level in men with non-dialysis-dependent chronic kidney disease.

  2010cited by this paper
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National

  2009cited by this paper
• Predicting the 30-Year Risk of Cardiovascular Disease: The Framingham Heart Study

  2009cited by this paper
• A new equation to estimate glomerular filtration rate.

  2009cited by this paper
• Report of the Asian Forum of Chronic Kidney Disease Initiative (AFCKDI) 2007. “Current status and perspective of CKD in Asia”: diversity and specificity among Asian countries

  2009cited by this paper
• Why is protein-energy wasting associated with mortality in chronic kidney disease?

  2009cited by this paper
• Alteraciones del metabolismo mineral en la enfermedad renal crónica estadios III, IV y V (no en diálisis)

  2008cited by this paper
• Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle?

  2008cited by this paper
• General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study

  2008cited by this paper
• A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease.

  2008cited by this paper
• [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].

  2008cited by this paper
• SPECIAL ANNOUNCEMENT: World Kidney Day: An idea whose time has come

  2006cited by this paper
• Epidemiology of dialysis patients and heart failure patients.

  2006cited by this paper
• World Kidney Day: an idea whose time has come

  2006cited by this paper
• Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study.

  2005cited by this paper
• Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.

  2004cited by this paper
• K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

  2002cited by this paper
• Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients.

  2001cited by this paper
• Prediction of coronary heart disease using risk factor categories.

  1998cited by this paper
• Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study.

  1994cited by this paper

• Evaluating Neutrophil Gelatinase-Associated Lipocalin in Pediatric CKD: Correlations with Renal Function and Mineral Metabolism

  2024cites this paper
• Extensive myocardial calcifications in a dialysis patient: A porcelain heart manifesting with abdominal pain

  2023cites this paper
• Prognostic models for chronic kidney disease: a systematic review and external validation.

  2020cites this paper
• Early predictors of cardiac dysfunction in Egyptian children with chronic kidney disease

  2019cites this paper
• Prevalence of Cardiovascular Risk Factors among Chronic Kidney Disease Patients Undergoing Hemodialysis in a Tertiary Care Center, Kathmandu, Nepal

  2019cites this paper
• Working Toward an Improved Understanding of Chronic Cardiorenal Syndrome Type 4.

  2018cites this paper
• Determination of serum calcium levels by 42Ca isotope dilution inductively coupled plasma mass spectrometry

  2017cites this paper
• Vitamin D levels and other biochemical parameters of mineral bone disorders and their association with diastolic dysfunction and left ventricular mass in young nondiabetic adult patients with chronic kidney disease.

  2017cites this paper
• Oxidized LDL: As a risk factor for cardiovascular disease in renal transplantation.

  2016cites this paper
• Cardiorenal Syndrome and the Role of the Bone-Mineral Axis and Anemia.

  2015cites this paper
• ASSOSIATION BETWEEN PARAMETERS OF MINERAL BONE METABOLISM AND SURVIVAL IN PATIENTS UNDERGOING CHRONIC HEMODIALYSIS

  2015cites this paper
• Clinical Skeletal Syndromes Associated with Parathyroid Disorders in Chronic Kidney Disease

  2015cites this paper
• Chronobiology and circadian rhythms establish a connection to diagnosis

  2014cites this paper